Cargando…
Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
Janus particles have emerged as a novel and smart material that could improve pharmaceutical formulation, drug delivery, and theranostics. Janus particles have two distinct compartments that differ in functionality, physicochemical properties, and morphological characteristics, among other conventio...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967574/ https://www.ncbi.nlm.nih.gov/pubmed/36839746 http://dx.doi.org/10.3390/pharmaceutics15020423 |
_version_ | 1784897298678939648 |
---|---|
author | Tan, Kei Xian Danquah, Michael K. Jeevanandam, Jaison Barhoum, Ahmed |
author_facet | Tan, Kei Xian Danquah, Michael K. Jeevanandam, Jaison Barhoum, Ahmed |
author_sort | Tan, Kei Xian |
collection | PubMed |
description | Janus particles have emerged as a novel and smart material that could improve pharmaceutical formulation, drug delivery, and theranostics. Janus particles have two distinct compartments that differ in functionality, physicochemical properties, and morphological characteristics, among other conventional particles. Recently, Janus particles have attracted considerable attention as effective particulate drug delivery systems as they can accommodate two opposing pharmaceutical agents that can be engineered at the molecular level to achieve better target affinity, lower drug dosage to achieve a therapeutic effect, and controlled drug release with improved pharmacokinetics and pharmacodynamics. This article discusses the development of Janus particles for tailored and improved delivery of pharmaceutical agents for diabetes treatment and antimicrobial applications. It provides an account of advances in the synthesis of Janus particles from various materials using different approaches. It appraises Janus particles as a promising particulate system with the potential to improve conventional delivery systems, providing a better loading capacity and targeting specificity whilst promoting multi-drugs loading and single-dose-drug administration. |
format | Online Article Text |
id | pubmed-9967574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99675742023-02-27 Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications Tan, Kei Xian Danquah, Michael K. Jeevanandam, Jaison Barhoum, Ahmed Pharmaceutics Review Janus particles have emerged as a novel and smart material that could improve pharmaceutical formulation, drug delivery, and theranostics. Janus particles have two distinct compartments that differ in functionality, physicochemical properties, and morphological characteristics, among other conventional particles. Recently, Janus particles have attracted considerable attention as effective particulate drug delivery systems as they can accommodate two opposing pharmaceutical agents that can be engineered at the molecular level to achieve better target affinity, lower drug dosage to achieve a therapeutic effect, and controlled drug release with improved pharmacokinetics and pharmacodynamics. This article discusses the development of Janus particles for tailored and improved delivery of pharmaceutical agents for diabetes treatment and antimicrobial applications. It provides an account of advances in the synthesis of Janus particles from various materials using different approaches. It appraises Janus particles as a promising particulate system with the potential to improve conventional delivery systems, providing a better loading capacity and targeting specificity whilst promoting multi-drugs loading and single-dose-drug administration. MDPI 2023-01-27 /pmc/articles/PMC9967574/ /pubmed/36839746 http://dx.doi.org/10.3390/pharmaceutics15020423 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tan, Kei Xian Danquah, Michael K. Jeevanandam, Jaison Barhoum, Ahmed Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications |
title | Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications |
title_full | Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications |
title_fullStr | Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications |
title_full_unstemmed | Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications |
title_short | Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications |
title_sort | development of janus particles as potential drug delivery systems for diabetes treatment and antimicrobial applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967574/ https://www.ncbi.nlm.nih.gov/pubmed/36839746 http://dx.doi.org/10.3390/pharmaceutics15020423 |
work_keys_str_mv | AT tankeixian developmentofjanusparticlesaspotentialdrugdeliverysystemsfordiabetestreatmentandantimicrobialapplications AT danquahmichaelk developmentofjanusparticlesaspotentialdrugdeliverysystemsfordiabetestreatmentandantimicrobialapplications AT jeevanandamjaison developmentofjanusparticlesaspotentialdrugdeliverysystemsfordiabetestreatmentandantimicrobialapplications AT barhoumahmed developmentofjanusparticlesaspotentialdrugdeliverysystemsfordiabetestreatmentandantimicrobialapplications |